LKB1 is a tumour suppressor that is mutated in Peutz-Jeghers syndrome and can regulates AMPK by directly phosphorylating it on its Thr172 residue of the catalytic α subunit to increase AMPK activity [15], [20]. Here, PRKAA2 is linked to neoplasm.